Utama › Mieloma Pelbagai › California › Baldwin Park
Kajian klinikal Mieloma Pelbagai di Baldwin Park, CA
23 kajian untuk Mieloma Pelbagai sedang mencari peserta di lokasi dalam dan sekitar Baldwin Park (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
Mengambil pesertaFasa 1
- City of Hope National Medical Center /ID# 280273, Duarte · 4 mi jauh
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
Mengambil pesertaFasa 1
- City of Hope, Duarte · 4 mi jauh
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
Mengambil pesertaFasa 1/2
- City of Hope National Medical Center, Duarte · 4 mi jauh
A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple Myeloma (DURGA-2)
Mengambil pesertaFasa 1
- Research Site, Duarte · 4 mi jauh
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
Mengambil pesertaFasa 3
- City of Hope Duarte, Duarte · 4 mi jauh
Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study
Mengambil pesertaFasa 2
- City of Hope Medical Center, Duarte · 4 mi jauh
A Study of IBI3003 in Subjects With Relapsed or Refractory Multiple Myeloma
Mengambil pesertaFasa 1/2
- City of Hope - Duarte, Duarte · 4 mi jauh
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Mengambil pesertaFasa 3
- City of Hope Duarte, Duarte · 4 mi jauh
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
Mengambil pesertaFasa 4
- City of Hope, Duarte · 4 mi jauh
Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma
Mengambil pesertaFasa 3
- City of Hope National Medical Center, Duarte · 4 mi jauh
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
Mengambil pesertaFasa 1
- City of Hope, Duarte · 4 mi jauh
A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma
Mengambil pesertaFasa 1/2
- Research Site, Duarte · 4 mi jauh
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma
Mengambil pesertaFasa 1/2
- Research Site, Duarte · 4 mi jauh
A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)
Mengambil pesertaFasa 1/2
- City of Hope, Duarte · 4 mi jauh
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
Mengambil pesertaFasa 1/2
- City of Hope National Medical Center /ID# 273132, Duarte · 4 mi jauh
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
Mengambil pesertaFasa 1
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi jauh
Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma
Mengambil peserta
- City of Hope, Duarte · 4 mi jauh
Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma
Mengambil pesertaFasa 2
- City of Hope Medical Center, Duarte · 4 mi jauh
Mezigdomide (CC-92480) Post Idecabtagene Vicleucel in Treating Patients With Relapsed Multiple Myeloma
Mengambil pesertaFasa 1
- City of Hope Medical Center, Duarte · 4 mi jauh
A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
Mengambil pesertaFasa 1
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi jauh
A Multicenter Prospective Observational Cohort Study Evaluating the Impact of Cancer-Directed Treatment and Medication Use, Including Cannabis Use, in Multiple Myeloma Patients
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- City of Hope Medical Center, Duarte · 4 mi jauh
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- City of Hope, Duarte · 4 mi jauh
Radioimmunotherapy (111Indium/225Actinium-DOTA-daratumumab) for the Treatment of Relapsed/Refractory Multiple Myeloma
Mengambil pesertaFasa 1
- City of Hope Medical Center, Duarte · 4 mi jauh
Kajian Mieloma Pelbagai di bandar lain
- New York City, NY60 kajian
- Boston, MA42 kajian
- Atlanta, GA41 kajian
- Houston, TX38 kajian
- Durham, NC37 kajian
- Nashville, TN32 kajian
- Denver, CO27 kajian
- Rochester, MN24 kajian
- St. Louis, MO24 kajian
- Columbus, OH24 kajian
- Chicago, IL22 kajian
- Seattle, WA22 kajian
Kajian lain di Baldwin Park
- Kanser Payudara45 kajian
- Leukemia Mieloid Akut40 kajian
- Kanser Kolorektal38 kajian
- Kanser Paru-paru Bukan Sel Kecil36 kajian
- Kanser (semua jenis)33 kajian
- Kanser Prostat30 kajian
- Kanser Metastatik30 kajian
- Sindrom Mielodisplastik26 kajian
- Kanser Ovari25 kajian
- Kanser Paru-paru24 kajian
- Kanser Perut22 kajian
- Leukemia Limfoblastik Akut21 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.